In short
Podcast Summary: CNBC's "Fast Money" - Episode on Nvidia and Boeing (5/23/24)
Episode Overview
- Hosts: Melissa Lee with traders Tim Seymour, Karen Feynman, Steve Grasso, and Julie Beal.
- Main Topics:
- Nvidia's stock performance post-earnings and stock split announcement.
- Boeing's cash flow issues and stock performance.
- Broader market reactions influenced by economic data and Federal Reserve outlook.
---
Key Discussions
Nvidia
Stock Performance and Market Sentiment
- Earnings Report and Stock Split:
- Nvidia shares surged over 9% after a strong earnings report and announcement of a 10-for-1 stock split.
- Despite this performance, the overall market reaction was negative, with the Dow dropping over 600 points, indicating that Nvidia's success did not translate into broader market confidence.
- Economic Indicators:
- The PMI report indicated stronger-than-expected economic signals, raising concerns about inflation and delaying potential Federal Reserve interest rate cuts.
- This led to a dichotomy in market performance; while Nvidia thrived, other sectors, especially banks and industrials, faced significant declines.
- Analyst Insights:
- Analysts highlighted the strength of Nvidia’s position within the AI sector, noting the broadening out of customer bases and applications.
- Skepticism remained regarding the sustainability of the AI rally and investor confidence amid potential economic slowdowns.
Boeing
Challenges and Future Outlook
- Cash Flow and Stock Decline:
- Boeing's stock fell more than 7% following warnings of significant cash burn and delivery issues, particularly concerning its 737 assembly line.
- The company adjusted its cash flow outlook negatively for 2024, raising concerns among investors about its long-term viability.
- Market Position:
- Despite current challenges, some analysts maintain a bullish outlook on Boeing, citing long-term demand for aircraft and potential recovery as assembly lines stabilize.
- Analysts pointed out critical deadlines approaching, including FAA discussions and DOJ litigations that could impact Boeing's operational landscape.
Broader Market Analysis
- Market Dynamics:
- The show discussed the influence of Federal Reserve policies on market performance, suggesting that uncertainty around rate cuts could lead to increased volatility.
- Traders speculated on the implications of Nvidia's strong performance versus broader market declines, indicating a possible disconnect between tech stocks and traditional sectors.
- Stock Picks and Strategies:
- The hosts shared their views on potential trades, with specific recommendations on stocks like International Paper and Ulta Beauty based on current market conditions.
- Options strategies were discussed for investors looking to manage risk in high-volatility environments, particularly relevant for Nvidia.
Additional Highlights
- Health Care Stocks:
- A brief discussion on upcoming healthcare stocks, influenced by data expected from the ASCO conference, indicating potential for major moves in biotech and pharmaceutical sectors.
- Live Nation's Antitrust Issues:
- Live Nation faced significant legal challenges with an antitrust suit filed by the DOJ, causing stock price declines amid allegations of monopolistic practices.
---
Conclusion The episode offered deep insights into Nvidia's robust growth amidst market caution and Boeing's ongoing struggles with cash flow and operational challenges. It highlighted the complex interplay between individual stock performances and broader economic indicators, emphasizing the influence of Federal Reserve policies on market sentiment. The discussions provided valuable perspectives for investors navigating a potentially volatile market landscape.
Actionable Takeaways
- For Nvidia: Consider options strategies to manage risk, especially after a substantial rally.
- For Boeing: Long-term investors may see value despite short-term challenges; monitor key upcoming deadlines that could impact the stock.
- General Market Strategy: Be cautious of market volatility influenced by economic data and Fed policies, and look for opportunities in sectors showing resilience, such as healthcare and technology.
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Transcript
Automatic transcript. May contain errors.0:02Live from the Nasdaq Market Sight in the heart of New York City's Times Square. This is Fast gold shares tumbling as the struggling aerospace giant says cash flow is going to be even worse than expected this year. Is there anything that can get the company back on track? We'll talk to one bull who still thinks there's upside to be had. And later, Elf Beauty Sock gets a makeover, Ticketmaster forced to face the music, and all the headlines out of the ASCO abstracts moving healthcare stocks. I'm Melissa Lee. Come to you live from Studio B at the NASDAQ. I'm the desk tonight. Tim Seymour, Karen Feynman, Steve Grasso, and Julie Beal.
0:45We start off with that big market divide, the Dow dropping more than 600 points for its worst day. In more than a year, the S &P 500 and Nasdaq pulling back after hitting record levels early in the session. That even adds, Nvidia soared more than 9 % on the back of an earnings report that few could find fault with. So why weren't the strong numbers from the third biggest stock in the U.S. enough to boost the rest of the market? Maybe ironically, even stronger numbers on the economy. A better than An expected read on PMI sent probabilities of September rate cut from nearly 58 percent yesterday to about even money right now.
1:19So our markets now all about the Fed once again. Tim, what happened today? I think the Fed is the most important dynamic in the market and will always be existentially. But I do think you have a case here where that PMI, that composite PMI, the services component, 54.8. Last number was around 51. We were actually starting to see the services weaken a bit. This was a very solid number for, as we all know, the biggest part of the U.S. economy, the part of the U.S. economy that also is very inflationary still. We've seen services inflation, whether it's been measurement in PCE and whatnot, come through on the high side.
1:53You also had a jobless claims number. I realize this is a very volatile series, but we were getting, if you were looking for a little weakness out of the labor markets, not there. You have jobless claims that are coming back in. You have initial claims that are pretty much sideways. You had a Fed yesterday. You had Fed minutes this week. There was nowhere in there did we hear we heard data dependent, data dependent. Well, right now, again, depending on how you looked at Fed fund futures yesterday, today, things got tighter. No question. Yeah. Karen. But yesterday, though, they did. You know, there was this higher for longer rhetoric.
2:23And I know people sort of dismissed it as somewhat dated, sort of like a 13F, where by the time it comes out, maybe it's not relevant anymore. But so this I don't know. It shouldn't be a surprise, really. So I feel like what happened in the market today, I mean, you had Boeing, which some idiosyncratic things that to me seemed more idiosyncratic than pervasive in the market. So you did that. But ultimately, it was just too weighty at the end of the day to took everything down other than a couple of things. Right. I know that you're watching the outside reversal that happened today with the S &P.
2:57Well, I think we're going to hit the 200 day moving average. So that's at 47.53-ish. It's a rising 200-day moving average. But when you look at what's going on right now, you have the Fed, as we kicked off the show, how many times did we say which is the most important thing? Now we know it today, right? But I also think that it's a day-by-day basis where you can have a sell-the-news event where everyone was waiting for NVIDIA. We got it. Okay, what's next? The Fed has been talking forever. They get blacked out in nine days or so. Buybacks get blacked out in a month and a half or a month or so, middle of June, basically.
3:37So I think you can weave that needle pretty perfectly to a sell-off late June where the bottom sort of falls out. Not forever, but a quick dip and then a quick bounce back into year end. Julie, were you surprised by this action? I mean, NVIDIA basically reinforced the whole AI narrative that has lifted the market so far this year. It's underscored and reinforced the notion that all these hyperscalers like the Microsoft, the biggest market caps in the world, are spending and that AI story is, in fact, intact. What happened today, in your view? It's a little surprising, I'll be honest. I mean, not only were the news out of NVIDIA good, but it also is seeing a broadening out.
4:16I had been really concerned that there was a lot of customer concentration at NVIDIA and that if any of these guys started to pull back, it would have meaningful results on their financials. But, you know, that wasn't the case. they're actually seeing a broadening out, which is really positive overall. But I think at the end of the day, with these hotter than expected prints and everyone reviewing what the Fed minutes were yesterday, a lot of the language was around, well, we need to see kind of three or four good prints before we want to really cut rates. And so as better prints come out, it just kind of keeps pushing things out and makes it harder to really feel confident that rate cuts are on the horizon.
4:52I mean, if anybody made a bear case for NVIDIA, I mean, all of those points were addressed in yesterday's print, right? Every single one, from the broadening to the potential air pocket with the transition to the Blackwell later this year. Which was going to happen to the Blackwell coming on earlier. He said, we're going to make a lot of money from Blackwell this year. And so considering how high expectations were, NVIDIA ended up not being a buy the rumor, sell the news. Yeah. In fact, I mean, even on a very bad day, it was up, I don't know, 7.5%, which is pretty impressive considering where it had been going in.
5:25But that just narrowing at the very top of, you know, Dell, I guess, at one point was only up like two bucks. Maybe it closed up a little higher. But this was just so strong, though, for NVIDIA that it didn't matter what else went on. However, for the rest of the market, it really did. Everything started to get hit. Industrials, banks, across the board. What they told us in terms of Blackwell, what they told us in terms of their core business, the expansion. I mean, doesn't this reinforce CapEx cycle for mega cap tech? Doesn't this reinforce a lot of the broader economic arguments that we know NVIDIA is more than that?
6:00But it's fascinating. And I thought this was the kind of that relief to buy. You can do the math. I mean, S &P was probably down 120 basis points if you remove NVIDIA today. You know, 5 % of the S &P, up 10%. That's pretty simple math. Steve, I actually I'm kind of impressed by the call to the 200 day because that's that's a that's a correction. I'm just going backwards, looking on the technicals. When we've tested the 50 and then the 100, we don't usually just stop at the 100. We rally a little bit, and then you wind up. So this is part of the last pullback. So it's part of the last pullback.
6:32But if you go back a couple of months, we did the same type of thing, where we tested all the moving averages, then bounced pretty effectively off the 200-day. But I think it's Pollyannish to think that we're just going to rise up to 5 ,700 going to year-round without a substantial pullback. By the way, we respect getting out there on a call. And I actually think that that's interesting because a lot of people, you get NVIDIA out of the way. We've had a good earning season. The Fed is kind of benign. Whatever we're saying about these Fed minutes, they're dated. I also think that NVIDIA, did anyone think it was kind of kooky that they came out with the split now?
7:07Why? We all know that the split doesn't do anything. But right-size splits go up and downside splits, reverse splits go down. but they don't do anything. The right size place doesn't do anything. The economics. The one thing it does do is allow options trading when a$1 ,000 stock is just too big to buy one country. Yeah, I just thought they pulled a lever of something. Why pull it now? Why pull it now versus last time around versus the time before that. You're so skeptical. A thousand stock's never been this expensive. They probably said at a thousand bucks we need to do this and we're pretty much there.
7:42The high of the street target, the last time I was on, a couple days ago, I said there's people who think that it's not expensive at$1 ,350. So I believe that was the high price target on the street. But when you look at it, it's just the timing of it is, yes, I am always skeptical because I want to see what the – there's always a – nobody comes across with that idea of splitting the stock. Just, hey, guys, what do you think we should do? Should we split the stock? I think when you get to$1 ,000 a share, you've got to start thinking about splitting the stock. Yeah, how many$1 ,000 a share stocks are there?
8:10I don't know. Right. I mean, we saw C. Chipotle no longer, right? But my thought is maybe we're seeing save it a little bit longer, and maybe you're coming to them because they're beating God higher, beating God higher, and maybe they're trying to do something because they think they're not going to. The flip side is that they've got so many arrows in their quiver that they're not worried about expending this one. Yeah, again, it's an interesting thought. I think they probably capital markets wise have some planning that's out there in the future. And this number makes some sense. But looking at semiconductors as a group relative to the S &P after a day like today.
8:50So the question is, you close really much almost in line with that March 7th top that came after the last NVIDIA. So we're right there. Intraday, we're through it. And I was saying, wow, semis have resumed leadership against the S &P. This is an important day. Maybe this is a double top, because, again, on a relative basis, If you look at ratios, semis to S &P is a very important thing to follow in this market. And we got to that top and we stalled. Tomorrow's another day. Next week's another week. But it's absolutely worth watching. Julie, is the message of today that there's still more gas in the tank for NVIDIA in the AI rally and you should be in that to avoid sort of the broader downside of the markets?
9:30It's always really hard to feel good about any kind of rally when it is so concentrated. And, you know, the broadening out is great. But again, if we're this dependent on this much capex from only a handful of companies, it doesn't take much for those companies to say, oh, you know what, it's the year of efficiency, we're actually going to pull back on our spending. And, you know, people act like that's impossible, that could never happen. But we don't really know, it's not written in stone. And I think the biggest challenge that we have is the business models and the business use cases around AI are still pretty nascent.
10:01And I think at some point for now, investors are like, sure, if you're going to do AI, I'm going to bid up your stock. But at some point, there has to be an economic business model around that. And investors will need to see that. All right. Well, our next guest says NVIDIA's breakout is just beginning. And even with today's bounce, it is still cheap compared to other chip names. Let's go off the charts with LPL Financial Chief Technical Strategist Adam Turnquist. So that's the question everybody has. How much higher? Can you answer that? I don't know if I can answer it, but the technicals can at least give us some guidance here because that's definitely the question on investors' minds right now with this latest breakout.
10:39When we look at the charts, we're seeing a breakout from what we call a bullish flag formation. If you measure that out, you look at the flagpole back from January and then the flag formation down to the lows, you can get an upside or a minimum upside technical price target right around$1 ,350. So some pretty good gains to go. the technical suggests the path of least resistance remains higher. Stock spent some time in the penalty box earlier. It's been just breaking out to new highs over the last two months after getting overbought. It looks like that uptrend is going to resume here for NVIDIA.
11:14So 1350 is your next level there. What do you make of the broader action in the markets that we saw today? Not a good finish, as we can see. A bearish engulfing candlestick. So we'll be watching to see what kind of downside we get. It's all about follow through coming into Friday. So we'll see how the market reacts. And if we do get a bit more follow through to the downside here, I'm not going to go with Steve's call to the 200 day moving average. But I do think you could get close to the maybe worst case scenario, 4 ,800. But I do think those April lows are going to be the key level to watch to see if we get there or not.
11:48And those are right around, I think, $48.50. Barish engulfing candlestick is what you said? Sounds ominous. It really does. Engulfing. You don't want anything to be engulfing a candlestick. But Adam, it's great to speak with you. Thank you. Thank you. Adam Turnquist. And if you're looking for a cheaper way to get into NVIDIA right now, let's bring in Mike Coe for an option strategy on this name. Mike, people feel like they missed it. People are afraid of owning the stock up here. What do you do? Yeah, I mean, it's a difficult one, right? So people may have been sitting there thinking, I'm going to wait until we get some news out of earnings.
12:24And then when I get the good news, then I'll buy it. And of course, they wake up and find that the stock is almost$90 higher. And that can be a difficult situation. Another difficult thing, and Karen was actually alluding to this, is going out and buying calls, for example. The September at-the-money calls cost roughly 11 % of the current stock price. So is there a way to get upside participation without necessarily either having to chase the stock at its current levels or just reaching out and needing the stock to make a big move higher for you to see profits, one way to do that would be to use a call spread risk reversal.
12:58I was looking, for example, at the September 1100 calls. You would buy those, sell the 1200 calls, and then also sell the 900 puts to help finance the purchase of those calls. Now, the interesting thing is that the sale of those two wing options actually more than pays for the 1100 call. So it It actually generates a standstill rate of return. So if the stock just sits here, or even if it drifts a little bit lower, goes a little bit higher, collect a little bit of premium. The downside risk in a trade like this is that you would have to own the stock at the strike of the put that you sold. But that actually represents an about 11 % discount to the current stock price.
13:32So you effectively would actually buy it at a price lower than where it was yesterday before they announced. So this is a way you can get some upside participation without actually chasing the stock right here. So, Mike, do you put a trade like this on and expect to sort of take off different legs depending on the stock moves? Are you holding this until expiration or some big event? Yeah, no, that's a really good question. And, of course, you can trade opportunistically around a trade like this. If the stock starts to rally, one of the things that's going to happen, of course, is that the closest to at-the-money call you have is going to appreciate.
14:06But very importantly, that downside put that you are short is going to begin to go down in value, both as a function of decay and as a function of the stocks move higher. And you would use that opportunity, of course, to cover that downside. And then essentially you're getting a much closer to free ride to the upside if you wanted to continue to maintain that long position. Mike, thank you. Mike Coe, you're an owner of NVIDIA, Karen. What are you doing at this point? You know, I did nothing today. I looked at calls. We talked on our midday call to sell what I I and probably many, many people have a much lower basis.
14:43So if you want, you know, I'm never going to be great at picking when to sell and then when to get back in. And the spread needs to be big enough that it is worthwhile for me to pay the taxes and jump back in and hope that that's just too hard for me to do. So I'm just staying long. All right. Let's get more on the names that can benefit from NVIDIA's rally. Let's go to Gene Munster of Deepwater Asset Management. Gene, good to see you. We want to go outside the obvious. So how are you thinking of sort of the next layer of trades out? So it starts with a little bit of a different view on what happened last night.
15:21I think that NVIDIA's results underscore that this is happening much faster than anyone could have imagined. And really, to put that into perspective, is that in the April 2023 quarter, NVIDIA's business was down 13 % year over year. This last quarter was up 260%. And the speed that things are happening really underscores the seismic shift of this transition to AI. In the midst of what we've talked about with AI for the last year and a half, there's just so many buzzwords around it. I'll just leave it at this, that the substance ultimately is going to exceed the hype. And when you have that perspective, the concept of worrying about inflation starts to fade away and you focus on what companies.
16:06And to answer your question, where do you go below the fold here? It's companies like TSM, ASML. I think that Google and Meta are particularly well positioned given they actually own the underlying models. So that's where we're looking for kind of this next shift. but this undoubtedly is going to be the underpinnings of a bull market for the next three to five years. So hyperscalers and hardware, are you thinking software at this point? Are you thinking about companies that will deploy AI for gains in their business that may be outside of technology? So currently most of our investments are not there, but I think that that's going to be this next wave, call it a year plus, kind of the two to five years.
16:48So eventually we'll get around to doing that. We invest in private and public companies. And so there are companies like Hugging Face, for example, that is on the model side. So there are other opportunities, I think, to invest in this wave that are not right down the middle with NVIDIA. Gene, when you look at Blackwell, it's about four or six times faster than Hopper. And you wind up seeing their integration with their new chips being so much faster than the previous iteration of it. Do you think you're going to run into a scenario where people just sort of get paralyzed and they want to wait for the newer chip?
17:25We've seen that a little bit. Or do you think the bandwidth of AI currently, people don't need the latest and greatest. Or there's a finite amount of companies like Amazon can consider doing whatever they're doing with Alexa and others need the latest and greatest. Have you added that to your calculus? Yes, absolutely. You're getting at the Osborne effect. This is that phenomenon of buyers waiting for the next kind of wave. And what surprised me related to last night's call is just the degree that NVIDIA is going out to its customers and saying, we're going to upgrade these chips once a year. And once you set that expectation, the probability that you have some air pocket before next cycle declines.
18:08If they would upgrade the chips every three years, this would be, you'd see these big boom and busts. But I think they are training their customers. We're gonna get new faster chips every year. This is kind of Moore's law type of improvements. And I think that does minimize. That was my big concern going into this quarter was the Osborne effect didn't play out. Gene, at what point with Nvidia do you think the growth will not warrant the chase? So, you know, right now seems like they've put to rest any question that they're not going to grow EPS 30 to 40 percent over the next couple of years. Makes the stock really quite attractive right here.
18:46And at some point, there might be even greater discounting mechanism for this stock based upon the move it's had and how important it's been. Any thoughts? I think into calendar 26, this is going to be wide open. When I say wide open, right now the street's going to, after the revisions last night, is looking for almost 30 % growth in calendar 25. I think they can grow 35 % plus 25, 26. So this is bigger. It's not just hyperscalers. It's industrial AI. There's an application layer. There's sovereign nations. This is the things that Jensen talks about. And I believe that. And based on that, NVIDIA still is not challenged.
19:22And I think that this growth story is going to continue. We're going to be saying it's deja vu. Thank you. Thanks. Great to get your thoughts. Gene Munster, at Deepwater. We've got some breaking news we want to get to. The SEC has made a decision on spot Ether ETFs. Contessa Brewer's got the details. Contessa. And it's been approved, Melissa. That's the big news coming in, that these ETFs based on the price of Ether have been approved for the NASDAQ, the CBOE, and the New York Stock Exchange, potentially paving the way for these ETFs to be listed later this year. Remember earlier this week, The agencies themselves had largely predicted, as had many of the experts on our air, that this would be denied based on some of the commentary we had heard around the Bitcoin ETFs being approved.
20:09But in fact, you've got VanEck, ARK Investments, BlackRock hoping to launch these ETFs tied to the second largest cryptocurrency. You're seeing Ether up about a percent and a half. Bitcoin, by comparison, took a little bit of a dip there. But again, that's the news coming in. The SEC has approved ETFs tied to Ether. All right, Contessa, thank you. Contessa Bruin, of course, we saw that big climb in Ether earlier this week. It is the E in Steve's wage acronym. What do you do with it now? The news is out. Yeah, you could always get some back in, Phil. And you're going to see that. Even with IBIT, which I own IBIT as well, you're going to see a demand just really accelerate.
20:51You're going to see institutions go for it. But the roadmap is what happened with IBIT. And this doesn't have to replicate it exactly, but to a large extent, you could see a 40 % or 50 % of the same move that IBIT had. All right, coming up, some big moves in health care stocks as we get some early headlines out of the ASCO conference. The companies with some key results out of their cancer treatment trials next. Plus shares of Alibaba dipping on reports of a possible bond sale, how much a company is looking to raise and what it could mean for the stock's next move. Don't go anywhere. More Fast Money in two.
21:31Welcome back to Fast Money. Investors getting a first look at the data being presented at the world's largest cancer conference next week. The ASCO abstracts just released at the top of the hour. Angelica Peoples has been sifting through the reams of reports and has some details moving the stocks. Hey, Angelica. Hey, Melissa. Yeah, tonight is a big night for cancer drugs. We have been going through these abstracts and looking at the data. Remember, these abstracts are basically a summary of the data that will be presented next week at ASCO, and that's the world's largest conference for cancer drugs.
22:02So I want to point you to two names that are moving right now. One of those is Maris. That stock is up about 16 percent after saying that its experimental drug given alongside Merck's Keytruda was well tolerated and showed promising results for a head and neck cancer in a phase two trial. Another name that's moving is Immunocore. The company is saying that its experimental drug for melanoma was well tolerated and showed promising clinical activity in a phase one. But that stock is down about six percent right now. And but we will note that it's trading with light volume. One metric wasn't as impressive as what investors were looking for, but I spoke to the company and they're saying that that metric isn't as important with this drug as it has been with other cancer drugs.
22:45Obviously, investors might not agree with that right now, but we're going to keep an eye on that and see how it shakes out. They have already started a phase three trial for that drug. We're going to keep going through the results and we'll get back to you with anything else we see. Melissa? Of course, the big moves, Angelica, will be seen by some of the smaller, like the biotech names, smaller market cap names. But the thinking, I think, of investors in terms of the large cap names is that potentially there could be deals to be made. So from that standpoint and ASCO, who are the large biotech or large pharmaceutical companies that are looking to possibly do a deal in cancer specifically?
23:18Yeah, that's something that we're definitely going to keep an eye on. Some of these names, these smaller companies like Immunocore and Maris are always names that people will be keeping their eye on to see if a large pharma might go after them. Next week, we are going to hear from some of the bigger companies like AstraZeneca, Novartis, J &J. They'll all be presenting data. So we'll have to see and listen if they have any indications on what exactly they're looking for. All right. Angelica, thank you. Angelica Peebles with the ASCO data dump is what we often like to call it, although it doesn't sound very nice, a dump of any sorts.
23:53But in terms of the pharma trade, in terms of biotech, you know, we're talking about sort of these smaller names. I don't think any of us are invested in Ameris or Aminocor. But in terms of the larger names, yes, you guys are. There could be deals. So when you look at in the last seven years, the cancer sales in these drugs. So you brought up who would be looking for a purchase. AstraZeneca has increased their cancer sales in the last three years by 3x. So has Merck. So has AbbVie. So has Johnson & Johnson. And so has Pfizer. So when you look at these names, those are the ones that are aggressively building out their portfolio.
Read the full transcript
24:27and I would look to them to be the acquirers. But the biggest takeaway is we're not talking about obesity drugs right now. We're talking about cancer. Maybe that leaves a host of other names that could rally. Yeah, you know, Gilead is one of those names that four years ago looked like they were making big moves. They were making acquisitions. And if you think about investor sentiment in Gilead right now as it relates to oncology, it's incredibly low. The fact is that Tridelby is the focal point, and I think there's a lot of competitive dynamics to think about there. Gilead is one of these names that has been dead money for a long time and one that I think would be great to have heard a headline here.
25:04Meanwhile, it's still an HIV story. Julie. I agree. As a small and mid-cap investor, we get asked all the time, are we investing in the biotechs? And the binary risk of these names is so hard. You really have to be an expert and know what you're doing. I think it is a much better way to play it on, you know, the companies that have demonstrated an ability to acquire these assets and push them through their pipelines like the larger names. All right. Coming up, some after hours action to bring you, Deckers, into it. Raw stores and Workday all reporting results of details from the quarters next.
25:33Plus, some fast movers catching our attention to the trades on a paper company and a Chinese tech giant. Why, these names are heading in opposite directions today. You're watching Fast Money Live from the Nasdaq Market Side in Times Square. Back right after this.
25:51Welcome back to Fast Money Stock. Selling off despite an NVIDIA's rally as expectations for a Fed rate cut dimmed again. The Dow falling 600 points, its worst stay in over a year. The S &P falling three quarters of a percent, and the Nasdaq down about four tenths of a percent. Shares of international paper jumping after a bullish call over at Jeffries. Analysts upgrading the name to a buy, raising the price target to 57 bucks. That's about a 30 percent increase from current levels. Alibaba, meantime, lower today after reports the Chinese tech giant is looking to sell$5 billion in convertible bonds.
26:20And some after hours action to bring you. Decker's Outdoors, the maker of Hoka sneakers, up after posting strong EPS and revenues into it, lower despite a beat on the top and the bottom lines. Raw stores higher after its own beat. And Workday dropping after reporting light full year subscription revenue guidance. Deckers and Raw. We've been talking about the consumer a lot. The stores, the retailers in the right sort of demographic are doing well. The ones in the wrong demographic, too bad. Yeah, and that's, again, a wildly competitive space and a space that actually has seen them have – look, they've had some great numbers.
26:56They've had a pretty good move there. And I think the discretionary spend is coming in aggressively. So raw stores, which is most interesting to me, pretty much similar to what we saw with TJX, right? If you're delivering value to the customer, they're there. Those are impressive numbers. Meantime, Barry Sternlich, Starwood Real Estate Trust, saying it is limiting redemptions to preserve capital. This after reports earlier this week that the$10 billion fund was hit by a wave of withdrawals in the first quarter and was running out of cash. The stock, the REIT, I should say, is down by three and three quarters of a percent.
27:30Remember the Wall Street Journal report just earlier this week. The headline was$10 billion real estate fund bleeding cash and running out of options. And the gist there is that, you know, these these sorts of vehicles were very popular when interest rates were really low and people wanted that five percent return. But in this environment, if they can't withstand the redemptions and the withdrawals, this sort of product may be a thing of the past. Well, if you are an investor in several of these and one of them is gating you, it does make you think, hmm, maybe I need to pull a little liquidity from the one where I can.
28:01Yeah. So it sort of starts a negative cycle for a little while. Yeah. And look, it feels like it was it was about six months ago we were we were fielding questions from Blackstone and the Breed. And this was something that, you know, a lot of people thought was something to be concerned about. Clearly, they didn't think it was. Clearly, it hasn't been. But if you think about where people have been on real estate, especially on commercial CRE, it's why we pushed around regional banks forever. So so it's not surprising that this stuff is bubbling. Is it bubbling to the surface? We'll see. But there was, I'm sorry, just this reprieve of expectation of big rate cuts.
28:36Right. For a little while. Sure. And now that that hasn't happened. And this could be the unintended consequences where everyone thought that the commercial real estate was going to get back in line because there was going to be cuts. And now if those cuts are kicked out, you could see this erupt the same way that we did with the regional banks. This could be the minefield. Coming up, another black eye for Boeing. Shares falling more than 7 % as the company warns of a cash burn this year. And deliveries won't be getting any better. All the problems facing the company next. And a lip gloss glow for shares of Elf Beauty as that stock notches its third best day ever.
29:11The eyeshadow earnings that had investors blushing and buying up this stock. Details on Fast Money Return.
29:22Welcome back to Fast Money. Boeing shares tumbling today, closing near-session lows. The Planemakers CFO warning that could burn through another$4 billion in cash this quarter and would be cash flow negative for the full year. Just a month ago, the company expected to have generated cash in fiscal 2024. The stock is down 34 percent this year, but one analyst still sees opportunity in this name. Nicholas Owens follows Boeing from Morningstar. He's got an overweight rating on the stock. Nicholas, great to have you with us. Thanks for buying me, Alyssa. I feel like it's been a series of disappointments.
29:55And just the very latest is not making the guidance that it just gave a month ago, two months ago now. Yeah, that's well, is it too soon to make the Charlie Brown and the football analogy? The big news today, I think, actually, in terms of what's hitting cash flows for Q2 and the plan was actually the China delivery. So the idea was that even as they're slowing down assembly, they could be delivering these other planes that are now 99 percent done. And that that would boost the cash flow. But so if you push out those China deliveries till sometime later in the year, hopefully, presumably, it exposes just how slow they're taking their their ramp up on the 737 assembly line, which is the healthy right thing to do.
30:40But it doesn't line up to the expectations for Q2. All right. So how do you get to 221? How do you get to your buy rating at this point in time? Sure. So, I mean, the big, from the point of view of the long term, so in three and five years, I think it's plausible that Boeing will have its assembly line squared away. The supply chain will be stabilized. They'll be producing many more of these 737s and doing so profitably. I still think that is the dominant and most plausible scenario. And 737 is about half the value of the whole franchise. So way back in February, after the January 5th thing, I took a look at some of the scenarios and the timing of the deliveries of 737s.
31:27And I took what I thought was a conservative take and we shaved our fair value at the time, which gets us to this 221. The real point is there's just still a ton of demand for these planes long term. I'm using a discounted cash flow model. I'm not necessarily benchmarking next quarter's earnings or multiplying from there. So that's part of how we get there.
31:51That's really the bottom line. There are, though, a couple of near-term sort of deadline or dates that investors are going to be watching very closely, and I imagine you are too. The May 30th deadline to file that 90-day report on quality improvements, and then also July 7th, which is the deadline by which the DOJ has to decide whether it will prosecute Boeing for violations of the deferred prosecution agreement. How do you handicap? How do you think about those two events in the context of the stock? Yeah, certainly looking forward to the FAA conversation next week. I'm hopeful that that's relatively positive.
32:24I mean, the CFO mentioned that they'd been in dialogue and really all they're doing is delivering their plan, which they will then garner feedback on and move forward with. And I think they're learning as they go here, as they really are digging deep into what's going on in the assembly line for the 737. The DOJ is a bit more of a wild card. If they were found criminally liable, actually, that could present pretty big complications. Usually, these sorts of things end up turning into just large fines. And, you know, basically with I think it's 500 million shares outstanding, a billion dollars is 50 cents off the off the value of the company in terms of fines.
33:11Yep. Nicholas, thank you. Nicholas Owens. Thanks for having me on Boeing over at Morningstar. You basically have a buy rating because you own it. I'm long Boeing. And this is the kind of a news that really bothers me. Some of the other stuff has been noise. We certainly know that there's been some some really awful events around the Boeing story. But you own Boeing for free cash flow and you've pushed this out. So if you own Boeing, you were expecting this to be a seven or eight percent free cash flow yield by 2026. It's clearly being pushed out. 787 production is also part of this. But I think that's actually not too bad.
33:47So frustrating. But but I think if you can be patient, the view is eventually this comes on back. And I think if you're patient with Boeing, you know, I expect to be in this trade for a couple of years. Yeah. I mean, if your time frame is longer, sure, Julie. But how do you how do you view this? Because I feel like one sort of pitfall in this stock has been thinking about a fine or the financial impact of something and calculating that into hit to EPS, hit to earnings per share. And it's been much bigger. I mean, in terms of a reputational issue, it's not just that hit. that takes off that amount of market.
34:25It's not surgical in terms of the impact. Yeah, I think that's right. And I think investors also have apprehension that what if there's more, right? It feels like we have a daily whistleblower that comes out, you know, trumpeting the problems that are happening here. And to me, as an investor, the regulatory overhang and not knowing the scale and scope of that is pretty scary. And it has implications for the rest of their fleets, too. So I think for me, even as a long-term investor who's really interested in an oligopoly, like that's ideal, right? And good value. This is tough. This is really, really tough.
35:00So when I heard the analysts talk about this, I kept thinking duopoly. That's the only reason why the bottom hasn't fallen out in the stock. If I look on a longer term chart, it looks like 120 is the level it wants to get there. There's obviously some pockets of support right here, but you got to think really quick. In April, they had the lowest jet deliveries that they've had since the pandemic. It's not over. Coming up, Elf's beautiful day. The makeup company is surging on the day after blowout results. We'll go inside the numbers after the break. Fast Money is back in two.
35:33Welcome back to Fast Money. Shares of Elf Beauty topping the tape today. The stock jumping almost 19 % after posting beats on the top and the bottom lines last night. The company marking its first billion-dollar sales year with revenues in the latest quarter up 77 % from a year ago. While guidance for the current quarter was less than expected, The company later suggested that the forecast was probably conservative. So is this beauty trade glammed up for future gains? And certainly the analyst commentary, Karen, has been that they think that the guidance is conservative. So they're just looking past it.
36:03Right. I mean, so that under promise over deliver thing. Reputation is a good one to have. I mean, this was impressive. I'm sort of intrigued. You had Target talk about some Ulta strength. This, I think, bodes well for Ulta, which we'll report next week. But that move has actually surprised me, the magnitude of this move in Elf. If I was a self-promoter, this would be an opportunity to talk about the Blisep. But you're not. But I'm not. And, of course, well, the E in Blisep's not doing so well. Estee Lauder, not Elf. Estee Lauder, by the way. You're going to change it to Elf? And I just wanted to make an announcement.
36:39Right. No, I think the real question is you're seeing different momentum in a handful of names here. And you are seeing also on the aspirational side in terms of different places where there are strengths and some brands that are taking market share. So Elf clearly a case where the credibility of the company, of the management team is such that people are following through here. I like the valuation in Estee going forward. Yeah. And remember, when Target reported, it did talk about the strength and beauty. Elf is a major has major market share at Target. And that was strength even in the midst of a not good earnings report, Julie.
37:16Yeah, absolutely. I think this has kind of been a consistent company that has been able to execute. And the way that it's really doing that is it's providing value for customers, right? It really is delivering on a prestige ability to give you the glowy skin that we all want, but at a price that's really right above mass. And I think their ability to do that is unique. The asset that they bought in Eturium gives them a really great footing in skincare. And so, you know, this stock is my personal NVIDIA. I've been looking at it for six months and haven't been able to pull the trigger, and I just feel so dumb.
37:51But, you know. Tim loves the glowy skin. I was going to say, well, Steve is clearly using Elf. I mean, you know. He's got some glow action there. I got a little one for the house. Oh, yeah. Coming up, it's time to face the music. Live Nation plunging as the DOJ files an antitrust suit against the Ticketmaster parent. The allegations and the dangers to the stock next. More Fast Money in two.
38:25Welcome back to Fast Money. Live Nation down nearly 8 % today after the Department of Justice announced it is suing the Ticketmaster parent company over alleged anti-competitive practices. The suit follows a probe launched by the DOJ back in 2022 over whether the company had a monopoly in the ticketing industry. Our Julia Borson spoke with the CFO earlier today. She Hey, Melissa, that's right. The DOJ, along with 30 state's attorneys general, are suing to break up Live Nation over alleged antitrust violations. And this is following a probe that's been going on for two years now. Now, the suit alleges that Live Nation Ticketmaster successfully threatened financial retaliation against potential entrance into the concert promotion space and threatened and retaliated against venues that work with rivals, that they blocked venues from using multiple ticketers, restricted artists' access to venues and acquired competitive threats.
39:13Now Live Nation's CFO responding. Here's what he told us. We believe that the Department of Justice has spent the last two years trying to figure out how to come to their predefined decision that they wanted to sue to break us up. That all they've accomplished over the past two years is find a handful of unrelated conduct that is very specific business practices to individual businesses that does not establish any basis for overturning the merger. Live Nation also saying that the DOJ's lawsuit will not solve issues around ticket prices, service fees and the like, and that the bulk of service fees go to venues.
39:50Melissa? All right. Julia, thank you. Julia Borson with the latest on Live Nation. Karen, you have been a shareholder of this. We are actually seeing the stock hit by it, although this has sort of been a looming issue. It has been a looming issue. And I at around this level, we talked about a couple of weeks ago and I said I didn't think anything would happen to the stock price while this is out there. Then it proceeded to go to 104. Now it's back down to the, now that this is not just rumored, this is happening. I think it's still way in the stock for quite a while. I mean, the business part is doing great.
40:22This is a significant overhang, though. I mean, this is a very popular sort of issue, popular meaning it appeals to the mainstream. People think, how expensive were Taylor Swift tickets, for instance? Why should we be paying this money? And this gets at it. Yeah, Taylor Swift tickets were expensive because she deserves it and because that's where the market is. But the fact of the matter is Ticketmaster controls the venue and they control the whole tour and no one can get in the way. And as Julia detailed, at least the accusations of bullying and predatory practices and retribution. So you want to go this way?
40:55You're not going to do too well in the music industry. That's the stuff that happens every day. The fact of the matter is, how do we all feel? How transparent do you feel the ticketing process is? You don't, right? It's totally opaque. And the inability to see the fact that concert tickets are largely sold the same way they were 20 years ago. And yet so many other things have innovated and evolved tells you a lot about this. I think they should be broken up and I think they will be. Julie. Yeah, I completely agree. This is a much more muscular DOJ that feels empowered to kind of take this on. And they're emboldened by, you know, the Ottoman army of Swifties that are really upset about what happened.
41:33And I think there's really no one that's going to defend Ticketmaster at this point. We can kind of all agree it's not a good service. And this is really one of those clear classic cases where monopolies just have a negative impact on consumers. I might not be the guy to defend them, but I think a lot, a lot, they're taking on a lot of flack where it's it really is the artists that are setting prices to a large extent. There's a lot of fees that are coupled on top of it. No one no one likes the fees. But I feel like we've been through this already with the government and doing this. I think this is a little more political than it's just about the fees.
42:06Up next, final trades.
42:15Time for the final trade. Let's go around the horn. Julie Beal. Health equity's core HSA business is very healthy, but they also benefit from higher interest rates, which is nice. Tim Seymour. I'm long international paper. I think the cycle has finally turned after 10 years in corrugated board, seaboard as we call it. But also there's an outstanding bid for the company. There's a new management team. There's Catalyst. Karen. Yeah. Ulta on the heels of it being down a lot and Target and L. Steve. So the W in my wage trade is Westrock, which is another paper trade. I like mine. I think there's a better upside potential of mine.
42:49All right. Thanks for watching Fast Money. See you back here tomorrow at 5 for more Fast. Mad Money with Jim Kramer starts right now. All opinions expressed by the Fast Money participants are solely their opinions and do not reflect the opinions of CNBC, NBCUniversal, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet, or another medium. You should not treat any opinion expressed on this podcast as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion. Such opinions are based upon information the Fast Money participants consider reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such.
43:31To view the full Fast Money disclaimer, please visit cnbc.com forward slash fastmoneydisclaimer.
From the publisher
Shares of Nvidia surging after earnings and its 10-for-1 stock split announcement, but after another big jump, is the stock still a buy? If the chip giant’s rally can keep running. Plus More headwinds for Boeing. The company announcing it expects to burn cash this year, and that deliveries won’t be getting any better. The latest Boeing bruise, and if this stock can turn things around.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
